Photon-counting CT for Intracranial Stent Assessment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5-90
SponsorXin Lou

About this trial

Intracranial atherosclerotic disease is an important cause of ischemic stroke, and intracranial stent implantation is increasingly used for patients with severe stenotic lesions. Evaluation of stent patency and detection of in-stent restenosis are essential during follow-up. Digital subtraction angiography (DSA) remains the reference standard for intracranial stent assessment; however, it is an invasive procedure associated with potential complications and radiation exposure. Conventional CT angiography may be limited by stent-related artifacts, including blooming artifact and beam-hardening effects, which can impair accurate evaluation of the stent lumen.

Eligibility criteria

Qualifiers

Age ≥18 years;

Patients with previously implanted intracranial arterial stents;

Undergoing follow-up CTA examination;

Available imaging data for analysis.

Disqualifiers

Severe motion artifacts;

Poor contrast enhancement;

Incomplete clinical or imaging data.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

200 Participants
are grouped into 1 trial group

Sponsors and collaborators

Xin Lou

Lead sponsor

Chinese PLA General Hospital

Sponsor institution